Genomic studies have shown that cross-talk between PR and ER in breast cancer cell lines and primary cells derived from patient breast tumors involves an extensive redirecting by PR of where ER binds on chromatin sites resulting in a reprogramming of target gene expression that attenuates the proliferative and growth promoting actions of E2 [79, 80]. This evidence concerns the gene ESR1 and breast carcinoma.